Medicalgorithmics Receives CE Certification for Next-Generation AI Algorithms DeepRhythmAI
Medicalgorithmics, a leading medical technology company listed on the sWIG80 index, has received CE certification for the next generation of its artificial intelligence algorithms, DeepRhythmAI (DRAI), used for analyzing heart ECG data. The new version of DRAI was previously approved for use in the US market by the FDA in 2022. Its commercial use will significantly strengthen the company’s position in the arrhythmia diagnostics market.